Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|March 11, 2011
Detection of Circulating Tumor Cells Using lmmunobead-PCRJ E Hardingham
Biotechniques|January 1, 1997
Immunobead RT-PCR: a sensitive method for detection of circulating tumor cellsM C Eaton, J E Hardingham, D Kotasek, et al.
Cancer Letters|May 18, 2004
Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinomaC M McIver, J M Lloyd, P J Hewett, et al.
BMC Molecular Biology|January 22, 2002
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancerS A Stephenson, S Slomka, E L Douglas, et al.
Bone Marrow Transplantation|January 1, 1993
Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantationJ E Hardingham, D Kotasek, R E Sage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2014
Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer researchP K Grover, A G Cummins, T J Price, et al.
Molecular Medicine (Cambridge, Mass.)|November 1, 1995
Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of diseaseJ E Hardingham, D Kotasek, R E Sage, et al.
Cancer Research|August 1, 1993
Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reactionJ E Hardingham, D Kotasek, B Farmer, et al.
International Journal of Cancer|March 17, 2000
Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel diseaseJ E Hardingham, P J Hewett, R E Sage, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 23, 2016
High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximabS S Kumar, Y Tomita, J Wrin, et al.
Pageof 2